Home » AdvanDx Gets FDA OK for Faster Staphylococcus Dx
AdvanDx Gets FDA OK for Faster Staphylococcus Dx
Molecular diagnostics firm AdvanDx said Thursday that it has received US Food and Drug
Administration clearance for faster versions of its Staphylococcus
aureus and S. aureus/coagulase-negative Staphylococci diagnostic tests.
GenomeWeb Daily News
GenomeWeb Daily News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May